![James Cavanaugh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Cavanaugh
Direktor/Vorstandsmitglied bei
SkinMedica, Inc.
Vermögen: 190 928 $ am 31.05.2026
Profil
James H.
Cavanaugh is currently Director at Diacrin, Inc. (Delaware) and SkinMedica, Inc., Managing Director & Partner at HealthCare Ventures LLC since 1989, and Trustee at the Gerald R.
Ford Presidential Foundation.
Former positions include Non-Executive Chairman at Shire Plc, Chairman at Diversa Corp., Vicuron Pharmaceuticals LLC, CardioKine, Inc., The Richard Nixon Foundation, and Shire Acquisition, Inc. (1999–2008).
Chairman at Verenium Corp.
(1992–2013).
Director roles at MedImmune LLC (2007), Middlebrook Pharmaceuticals, Inc. (1999–2010), PharmAthene, Inc. (2007–2011), Colorescience Corp., Unihealth America, Inc., Marine National Bank (Irvine, California) as Founding Director, Nixon Group, Senseonics, Inc., Xanodyne Pharmaceuticals, Inc., Orqis Medical Corp., Healthcare Acquisition Corp., National Venture Capital Association, Pharmaceutical Research & Manufacturers Association, Consumer Healthcare Products Association, and Cypherpunk Technologies, Inc. (Independent Director, 2016–2026).
Deputy Director at Domestic Policy Council.
President at Smithkline Beckman Corp, Smithkline & French Laboratories US, Inc. (1985–1989), Smithkline Clinical Laboratories (1981–1985), French Laboratories U.S., Inc. (1989), Allergan Sales LLC, and Allergan International.
Deputy Assistant Secretary at US Department of Health & Human Services.
Trustee at The National Center for Genome Resources.
Education includes undergraduate degree from Fairleigh Dickinson University (1959), graduate degree from the University of Iowa (1961), and doctorate from the University of Iowa (1964).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 168.963 ( 0,16 % ) | 190 928 $ | 31.05.2026 |
Aktive Positionen von James Cavanaugh
| Unternehmen | Position | Beginn |
|---|---|---|
HealthCare Ventures LLC
 HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures invests in companies located in the United States. The firm target companies operating in the fields of life sciences, pharmaceuticals and biotechnology. It provides financing for early and later stage capital requirements. | Private Equity Investor | 01.01.1989 |
Diacrin, Inc. (Delaware)
 Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Develops human cell transplant therapeutic products | Direktor/Vorstandsmitglied | - |
SkinMedica, Inc.
 SkinMedica, Inc. Medical DistributorsDistribution Services Develops dermatology products | Direktor/Vorstandsmitglied | - |
Gerald R. Ford Presidential Foundation
 Gerald R. Ford Presidential Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization which supports the exhibitions and programs of library and museum which includes noted speakers, educational activities, and community events | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von James Cavanaugh
| Unternehmen | Position | Ende |
|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. | Direktor/Vorstandsmitglied | 18.06.2026 |
| VERENIUM CORP | Vorsitzender | 31.10.2013 |
PharmAthene, Inc.
 PharmAthene, Inc. BiotechnologyHealth Technology Develops bio therapeutics to address biological pathogens and chemicals | Direktor/Vorstandsmitglied | 25.04.2011 |
Middlebrook Pharmaceuticals, Inc.
 Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pulsatile drug products | Direktor/Vorstandsmitglied | 20.03.2010 |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Vorsitzender | 23.05.2008 |
Ausbildung von James Cavanaugh
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
78
Beziehungen ersten Grades
38
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 38 |
|---|---|
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Diacrin, Inc. (Delaware)
Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Develops human cell transplant therapeutic products | Health Technology |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
Diversa Corp.
 Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops genomic tools and biological technology for the agricultural industry | Commercial Services |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pulsatile drug products | Health Technology |
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology Develop drugs and pharmaceuticals for the treatment and prevention of heart failure | Health Technology |
SkinMedica, Inc.
SkinMedica, Inc. Medical DistributorsDistribution Services Develops dermatology products | Distribution Services |
Shire Acquisition, Inc.
 Shire Acquisition, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
PharmAthene, Inc. /Old/
 PharmAthene, Inc. /Old/ BiotechnologyHealth Technology Develops biotherapeutics to address biological pathogens and chemicals | Health Technology |
Colorescience Corp.
 Colorescience Corp. Specialty StoresRetail Trade Manufactures and sells mineral based makeup products | Retail Trade |
HealthCare Ventures LLC
HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures invests in companies located in the United States. The firm target companies operating in the fields of life sciences, pharmaceuticals and biotechnology. It provides financing for early and later stage capital requirements. | Finance |
Unihealth America, Inc.
 Unihealth America, Inc. Life/Health InsuranceFinance Health maintenance organization | Finance |
Marine National Bank (Irvine, California)
 Marine National Bank (Irvine, California) Major BanksFinance National commercial bank | Finance |
Nixon Group
 Nixon Group Miscellaneous Commercial ServicesCommercial Services Provides public relations and marketing services | Commercial Services |
Smithkline Beckman Corp
 Smithkline Beckman Corp Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Fairleigh Dickinson University
 Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Senseonics, Inc.
 Senseonics, Inc. Electronic ComponentsElectronic Technology Develops transformative glucose monitoring products | Electronic Technology |
Xanodyne Pharmaceuticals, Inc.
 Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Orqis Medical Corp.
 Orqis Medical Corp. Hospital/Nursing ManagementHealth Services Develops medical devices and solutions for heart problems | Health Services |
Healthcare Acquisition Corp.
 Healthcare Acquisition Corp. Financial ConglomeratesFinance Acquisition vehicle | Finance |
US Department of Health & Human Services
 US Department of Health & Human Services General GovernmentGovernment Governmental department | Government |
Domestic Policy Council
 Domestic Policy Council General GovernmentGovernment Coordinates the domestic policy-making process | Government |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services Provides business association services | Commercial Services |
Gerald R. Ford Presidential Foundation
Gerald R. Ford Presidential Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization which supports the exhibitions and programs of library and museum which includes noted speakers, educational activities, and community events | Commercial Services |
Pharmaceutical Research & Manufacturers Association | |
The Richard Nixon Foundation
 The Richard Nixon Foundation Miscellaneous Commercial ServicesCommercial Services Operates as foundation for library & museums | Commercial Services |
The National Center for Genome Resources
 The National Center for Genome Resources Miscellaneous Commercial ServicesCommercial Services Provides biomedical research services | Commercial Services |
Verenium Corp.
 Verenium Corp. BiotechnologyHealth Technology Produces cellulosic ethanol derived from multiple biomass feedstocks | Health Technology |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology Develops bio therapeutics to address biological pathogens and chemicals | Health Technology |
Consumer Healthcare Products Association
 Consumer Healthcare Products Association Miscellaneous Commercial ServicesCommercial Services Operates as national trade association representing manufacturers and marketers of medicines, dietary supplements, and consumer medical devices | Commercial Services |
Smithkline & French Laboratories US, Inc. | |
Smithkline Clinical Laboratories | |
Allergan Sales LLC
 Allergan Sales LLC Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
French Laboratories U.S., Inc. | |
Allergan International
 Allergan International Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company | Health Technology |
Leap Therapeutics, Inc.
 Leap Therapeutics, Inc. BiotechnologyHealth Technology Engages in clinical stage immuno-oncology | Health Technology |
